SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-22-000900
Filing Date
2022-01-20
Accepted
2022-01-20 19:55:17
Documents
2
Period of Report
2022-01-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp165456_4-spurr.html 4  
1 FORM 4 dp165456_4-spurr.xml 4 3467
2 EXHIBIT 24 dp165456_ex24.htm EX-24 9878
  Complete submission text file 0000950103-22-000900.txt   15070
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BAUSCH HEALTH COMPANIES INC. 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
Spurr Robert (Reporting) CIK: 0001543795 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 22543797